Article Details
Retrieved on: 2021-05-13 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wainwright analyst Andrew Fein reiterated a Buy rating on Strongbridge Biopharma (SBBP) today and set a price target of $10.00. The company's ...
Article found on: www.smarteranalyst.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here